Gene Pathway Visualization for Clinical Decision Support
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and treating cancer rely heavily on molecular signatures that do not explicitly capture underlying cellular mechanisms, limiting their ability to provide comprehensive therapy recommendations, especially for patients outside clinical guidelines.
Innovation Solution
A system and method for visually representing gene activity levels and pathways using a validated pathway database and visual grammar, which facilitates the interpretation of high-throughput molecular profiling data to provide actionable therapy recommendations for clinicians.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If molecular signatures are used for diagnosis and therapy selection, then diagnostic capability is improved, but the ability to capture underlying cellular mechanisms is limited
Solution Approach 1:
The patent transforms flat molecular signature data into three-dimensional pathway visualizations that add spatial and contextual dimensions. This allows clinicians to see not just which genes are altered, but how they interact within biological pathways, preserving mechanistic information while maintaining diagnostic precision.
Solution Approach 2:
The patent introduces pathway databases and visualization software as intermediaries between raw molecular data and clinical interpretation. These intermediaries organize gene expression data into biologically meaningful pathway contexts, recovering mechanistic information that would otherwise be lost in traditional molecular signature analysis.
2Measurement precision
If high throughput molecular data is analyzed through statistical feature selection, then patient classification is improved, but explicit capture of genetic regulation impact is limited
Solution Approach 1:
The patent segments the complex task of genetic regulation analysis into manageable pathway components. By dividing the genome into functional pathways and visualizing them separately, the system maintains classification accuracy while making genetic regulation mechanisms explicitly visible and interpretable for clinical decision-making.
3Measurement precision
If pathway visualization systems are implemented, then therapy recommendation accuracy is improved, but system complexity increases
Solution Approach 1:
The patent uses digital copies of pathway data from validated databases rather than requiring complex real-time analysis infrastructure. By pre-computing and storing pathway information in standardized formats, the system achieves high therapy recommendation accuracy while keeping the visualization system itself relatively simple and computationally efficient.
Data Source
AI summary
When generating visual representations of gene activity pathways for clinical decision support, a validated pathway database that stores a plurality of validated pathways is accessed, wherein each pathway describes at least one interaction between a plurality of genes. A processor (18) is configured to execute computer-executable instructions stored in a memory (16), the instructions comprising visually representing gene activity level (28) for at least one gene across a plurality of populations, retrieving a pathway (32) from the validated pathway database, wherein the pathway includes the at least one gene, and visually representing gene activity levels for all genes in the pathway. The instructions further comprise a formal visual grammar representation visually representing information flow (36) through interactions between genes in pathway, linking the visual representation of the information flow to actionable information (42) for a clinician, and outputting the visual representation of the information flow and the linked actionable information to the to the clinician.